Zusammenfassung
Neben der medikamentösen Therapie haben eine spezifische Atem- und Bewegungstherapie sowie chirurgische und seit Kurzem auch interventionelle Verfahren ihren festen Platz in der Behandlung von Patienten mit pulmonaler Hypertonie (PH). Ein speziell für PH-Patienten entwickeltes Trainingsverfahren kann die Beschwerden, körperliche Belastbarkeit, Lebensqualität und das Langzeitüberleben deutlich verbessern. Bei Patienten mit chronisch thromboembolischer pulmonaler Hypertonie ist die pulmonale Endarteriektomie die Therapie der Wahl. Für inoperable Patienten ist die sog. pulmonale Ballonangioplastie eine neue Therapieoption. Im Endstadium einer PH ist die Lungentransplantation ein effektives Verfahren zur Verbesserung von Lebensqualität und Lebenserwartung.
Abstract
Besides drug-based treatment, specific breathing and exercise training, as well as surgical and, more recently, interventional methods are established or evolving treatment options for patients with pulmonary hypertension (PH). An exercise and rehabilitation program developed specifically for PH patients has been shown to improve symptoms, exercise capacity, quality of life and long-term survival. For patients with chronic thromboembolic pulmonary hypertension (CTEPH), pulmonary endarterectomy (PEA) is the treatment of choice. Pulmonary balloon angioplasty (BPA) is a promising new therapeutic option for inoperable CTEPH patients. For patients with end-stage PH, lung transplantation is an effective procedure for improving quality of life and extending lifespan.
Abbreviations
- CTEPH:
-
Chronisch thromboembolische pulmonale Hypertonie
- HLM:
-
Herz-Lungen-Maschine
- ECMO:
-
Extrakorporale Membranoxygenierung
- PEA:
-
Pulmonale Endarteriektomie
- mPAP:
-
Mittlerer pulmonalarterieller Druck
- PAOP:
-
Pulmonalarterieller Okklusionsdruck (Wedge-Druck)
- PVR:
-
Pulmonalvaskulärer Widerstand
- BPA:
-
Pulmonale Ballonangioplastie
- LTX:
-
Lungentransplantation
Literatur
Becker-Grunig T, Klose H, Ehlken N et al (2013) Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease. Int J Cardiol 168:375–381
Berman M, Tsui S, Vuylsteke A et al (2008) Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy. Ann Thorac Surg 86:1261–1267
Chan L, Chin LM, Kennedy M et al (2013) Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest 143:333–343
De Perrot M, Granton JT, Mcrae K et al (2012) Outcome of patients with pulmonary arterial hypertension referred for lung transplantation: a 14-year single-center experience. J Thorac Cardiovasc Surg 143:910–918
Ehlken N, Verduyn C, Tiede H et al (2014) Economic evaluation of exercise training in patients with pulmonary hypertension. Lung 192:359–366
Galie N, Corris PA, Frost A et al (2013) Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol 62:D60–D72
Galie N, Hoeper MM, Humbert M et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34:1219–1263
Grunig E (2012) Treatment of pulmonary arterial hypertension in connective tissue disease. Drugs 72:1039–1056
Grunig E, Ehlken N, Ghofrani A et al (2011) Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension. Respiration 81:394–401
Grunig E, Lichtblau M, Ehlken N et al (2012) Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respir J 40:84–92
Hoeper MM, Mayer E, Simonneau G et al (2006) Chronic thromboembolic pulmonary hypertension. Circulation 113:2011–2020
Inami T, Kataoka M, Shimura N et al (2013) Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty. JACC Cardiovasc Interv 6:725–736
Jenkins DP, Madani M, Mayer E et al (2013) Surgical treatment of chronic thromboembolic pulmonary hypertension. Eur Respir J 41:735–742
Kataoka M, Inami T, Hayashida K et al (2012) Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 5:756–762
Kim NH, Delcroix M, Jenkins DP et al (2013) Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 62:D92–D99
Madani MM, Auger WR, Pretorius V et al (2012) Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann Thorac Surg 94:97–103 (discussion 103)
Mayer E, Jenkins D, Lindner J et al (2011) Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 141:702–710
Mayer E, Klepetko W (2006) Techniques and outcomes of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 3:589–593
Mereles D, Ehlken N, Kreuscher S et al (2006) Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation 114:1482–1489
Mizoguchi H, Ogawa A, Munemasa M et al (2012) Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 5:748–755
Nagel C, Prange F, Guth S et al (2012) Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension. PLoS One 7:e41603
Orens JB, Estenne M, Arcasoy S et al (2006) International guidelines for the selection of lung transplant candidates: 2006 update – a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 25:745–755
Simonneau G, Delcroix M, Lang I et al (2013) Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results of a prospective registry comparing operated versus non-operated patients. Am J Respir Crit Care Med 187:A5 365
Smeritschnig B, Jaksch P, Kocher A et al (2005) Quality of life after lung transplantation: a cross-sectional study. J Heart Lung Transplant 24:474–480
Thistlethwaite PA, Madani MM, Kemp AD et al (2006) Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes. Ann Thorac Surg 82:2139–2145
Toyoda Y, Toyoda Y (2014) Heart-lung transplantation: adult indications and outcomes. J Thorac Dis 6:1138–1142
Vuylsteke A, Sharples L, Charman G et al (2011) Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial. Lancet 378:1379–1387
Yuan P, Yuan XT, Sun XY et al (2015) Exercise training for pulmonary hypertension: a systematic review and meta-analysis. Int J Cardiol 178:142–146
Yusen RD, Edwards LB, Kucheryavaya AY et al (2014) The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report–2014; focus theme: retransplantation. J Heart Lung Transplant 33:1009–1024
Guth S, Kramm T, Wiedenroth C, Mayer E (2014) Pulmonale Endarteriektomie bei chronisch-thrombembolischer pulmonaler Hypertonie. Z Herz Thorax Gefaßchir 28:178–184
Einhaltung ethischer Richtlinien
Interessenkonflikt. S. Guth hat Vortragshonorare der Firmen Actelion, Bayer und Pfizer erhalten.
N. Ehlken: Kein Interessenkonflikt.
T. Kramm: Vortragshonorare der Firmen Actelion und Bayer.
C. Wiedenroth: Kein Interessenkonflikt.
E. Grünig: Kein Interessenkonflikt.
E. Mayer: Vortragshonorare der Firmen Actelion, Bayer, GSK und Pfizer.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guth, S., Ehlken, N., Kramm, T. et al. Nichtmedikamentöse Therapie bei pulmonaler Hypertonie. Pneumologe 12, 401–409 (2015). https://doi.org/10.1007/s10405-015-0882-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10405-015-0882-4